mitoxantrone has been researched along with Immunoblastic Large-Cell Lymphoma in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabanillas, F | 1 |
| Rodriguez-Diaz Pavón, J | 1 |
| Hagemeister, FB | 1 |
| McLaughlin, P | 1 |
| Rodriguez, MA | 2 |
| Romaguera, JE | 1 |
| Dong, K | 1 |
| Moon, T | 1 |
| Wilder, RB | 1 |
| Tucker, SL | 1 |
| Ha, CS | 1 |
| Hess, MA | 1 |
| Cabanillas, FF | 1 |
| Cox, JD | 1 |
2 trials available for mitoxantrone and Immunoblastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; | 1998 |
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 2001 |